IGF-1 drives muscle repair, while BPC-157 and TB-500 accelerate angiogenesis, tendon healing, and inflammation reduction
Tan, M., Lamendola, C., Luong, R., McLaughlin, T
Hilger, D
In the SURMOUNT-1 trial, tirzepatide produced average weight reductions of 15.0%, 19.5%, and 20.9% at studied doses compared with 3.1% with placebo over 72 weeks
More widespread use of SGLT2i in type 1 diabetes will necessitate implementation of strategies to assess and mitigate DKA risk, including preventative measures, patient education and continuous ketone monitoring, as well as a better understanding of the potential benefits for clinical cardiorenal outcomes, especially in high-risk populations such as people with CKD (Table 2) [46, 47]
The lead author owns a store called Reverse Skin Aging, which sells these peptides